Inactivated Influenza Vaccine (TIV)

• Immunogenicity, Efficacy, and Effectiveness of TIV Children
• Vaccine Effectiveness for Children Aged 6 Months-8 Years Receiving Influenza Vaccine for the First Time
• Adults Aged <65 Years
• Older Adults
• TIV Dosage, Administration, and Storage
• Adverse Events after Receipt of TIV
• TIV Safety for Persons with HIV Infection
• Guillain-Barré Syndrome and TIV
  • Use of TIV among Patients with a History of GBS
• Vaccine Preservative (Thimerosal) in Multidose Vials of TIV

Back